Show simple item record

dc.contributorFacultad de Veterinariaes_ES
dc.contributor.authorSahagún, Ana M.
dc.contributor.authorGarcía, Juan J.
dc.contributor.authorSierra, Matilde 
dc.contributor.authorFernández, Nélida
dc.contributor.authorDiez, M. José
dc.contributor.authorTerán, M. Teresa 
dc.contributor.otherFarmacologiaes_ES
dc.date2000-03-10
dc.date.accessioned2015-09-03T13:37:48Z
dc.date.available2015-09-03T13:37:48Z
dc.date.issued2015-09-03
dc.identifier.citationJournal of Veterinary Pharmacology and Therapeutics, 2000, n. 23es_ES
dc.identifier.urihttp://hdl.handle.net/10612/4556
dc.descriptionP. 189.192es_ES
dc.description.abstractSigns of temporary toxicosis at oral <lose levels as small as 16 mg/kg have been observed in this animal species (Smith & Bell, 1971), but a narrow therapeutic index has not been shown for levamisole in goats. So, and based on the high bioavailability and good absorption obtained in this study, the s.c. route appeared to be a practical option for levamisole administration to goats.es_ES
dc.languageenges_ES
dc.publisherWiley-Blackwelles_ES
dc.subjectFarmacologíaes_ES
dc.subjectMedicina. Saludes_ES
dc.subject.otherLevamisoles_ES
dc.subject.otherGoatses_ES
dc.subject.otherSubcutaneouses_ES
dc.subject.otherBioavailabilityes_ES
dc.titleSubcutaneous bioavailability of levamisole in goatses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.peerreviewedSIes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record